Compounds > lycodine
Page last updated: 2024-12-11

lycodine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lycodine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5462443
CHEBI ID6591
SCHEMBL ID12487986
MeSH IDM0589639

Synonyms (19)

Synonym
20316-18-1
C09876 ,
lycodine
1h-5,10b-propano-1,7-phenanthroline, 2,3,4,4a,5,6-hexahydro-12-methyl-, (4ar-(4aalpha,5alpha,10balpha,12r*))-
unii-7k0nx2m1nn
7k0nx2m1nn ,
SCHEMBL12487986
CHEBI:6591
lycodine [mi]
lycodine, (-)-
1h-5,10b-propano-1,7-phenanthroline, 2,3,4,4a,5,6-hexahydro-12-methyl-, (4ar,5s,10br,12r)-
(4ar-(4a.alpha.,5.alpha.,10b.alpha.,12r*))-2,3,4,4a,5,6-hexahydro-12-methyl-1h-5,10b-propano-1,7-phenanthroline
surecn12487986
Q5975178
12-methyl-2,3,4,4a,5,6-hexahydro-1h-5,10b-propano-1,7-phenanthroline
DTXSID90942465
(1r,9s,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
(1s,9r,10r,16r)-16-methyl-6,14-diazatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene
AKOS040752797
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenanthrol
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (82.35)24.3611
2020's3 (17.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.44 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
decalin
decalin: RN given refers to cpd without isomeric designation; don't confuse with decaline which has a nitrogen at the juncture of the two rings;. trans-decalin : The trans-stereoisomer of decalin.. decalin : An ortho-fused bicyclic hydrocarbon that is the decahydro- derivative of naphthalene.		2.0810ortho-fused bicyclic hydrocarbonsolvent
oxazoles
Oxazoles: Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.. 1,3-oxazole : A five-membered monocyclic heteroarene that is an analogue of cyclopentadiene with O in place of CH2 at position 1 and N in place of CH at position 3.. oxazole : An azole based on a five-membered heterocyclic aromatic skeleton containing one N and one O atom.		2.08101,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
pyridine n-oxide
pyridine N-oxide: RN given refers to parent cpd. pyridine N-oxide : The pyridine N-oxide derived from the parent pyridine. It is a drug metabolite of the antihypertensive agent pinacidil.		2.1510pyridine N-oxidesdrug metabolite
alkenes
[no description available]		2.0810
phenylpropanolamine
fawcettimine: from Lyopodium; structure in first source		2.1110azaspiro compound
glycosides
[no description available]		7.1710
complanadine a
complanadine A: a Lycopodium alkaloid; structure in first source		7.7930
complanadine b
complanadine B: isolated from Lycopodium complanatum; structure in first source		2.5220
ConditionIndicatedRelationship StrengthStudiesTrials